Pfizer Inc (PFE)
25.36
-0.06
(-0.24%)
USD |
NYSE |
Apr 18, 11:12
Pfizer Cash and Short Term Investments (Quarterly): 12.69B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.69B |
| September 30, 2023 | 44.18B |
| June 30, 2023 | 44.78B |
| March 31, 2023 | 19.97B |
| December 31, 2022 | 22.73B |
| September 30, 2022 | 36.12B |
| June 30, 2022 | 33.30B |
| March 31, 2022 | 23.90B |
| December 31, 2021 | 31.07B |
| September 30, 2021 | 29.70B |
| June 30, 2021 | 21.70B |
| March 31, 2021 | 13.67B |
| December 31, 2020 | 12.22B |
| September 30, 2020 | 10.50B |
| June 30, 2020 | 11.39B |
| March 31, 2020 | 10.35B |
| December 31, 2019 | 9.646B |
| September 30, 2019 | 9.087B |
| June 30, 2019 | 12.91B |
| March 31, 2019 | 11.62B |
| December 31, 2018 | 18.83B |
| September 30, 2018 | 17.24B |
| June 30, 2018 | 13.43B |
| March 31, 2018 | 11.42B |
| December 31, 2017 | 19.99B |
| Date | Value |
|---|---|
| September 30, 2017 | 16.92B |
| June 30, 2017 | 14.33B |
| March 31, 2017 | 14.56B |
| December 31, 2016 | 17.85B |
| September 30, 2016 | 14.37B |
| June 30, 2016 | 20.94B |
| March 31, 2016 | 19.44B |
| December 31, 2015 | 23.29B |
| September 30, 2015 | 20.66B |
| June 30, 2015 | 30.26B |
| March 31, 2015 | 27.71B |
| December 31, 2014 | 36.12B |
| September 30, 2014 | 33.45B |
| June 30, 2014 | 34.05B |
| March 31, 2014 | 33.88B |
| December 31, 2013 | 32.41B |
| September 30, 2013 | 33.68B |
| June 30, 2013 | 33.71B |
| March 31, 2013 | 35.35B |
| December 31, 2012 | 32.40B |
| September 30, 2012 | 22.97B |
| June 30, 2012 | 24.31B |
| March 31, 2012 | 23.97B |
| December 31, 2011 | 26.45B |
| September 30, 2011 | 28.96B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.087B
Minimum
Sep 2019
44.78B
Maximum
Jun 2023
21.58B
Average
19.97B
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 10.94B |
| Gilead Sciences Inc | 7.264B |
| Johnson & Johnson | 22.93B |
| Viking Therapeutics Inc | 362.08M |
| Moderna Inc | 8.604B |